Compare CHE & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHE | AFRM |
|---|---|---|
| Founded | 1970 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 19.6B |
| IPO Year | 1994 | 2020 |
| Metric | CHE | AFRM |
|---|---|---|
| Price | $390.15 | $48.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 29 |
| Target Price | ★ $498.00 | $83.65 |
| AVG Volume (30 Days) | 236.4K | ★ 5.5M |
| Earning Date | 06-02-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.60% | N/A |
| EPS Growth | N/A | ★ 108.98 |
| EPS | ★ 18.34 | 0.60 |
| Revenue | $2,529,978,000.00 | ★ $3,224,412,000.00 |
| Revenue This Year | $6.60 | $30.69 |
| Revenue Next Year | $6.15 | $24.02 |
| P/E Ratio | ★ $21.77 | $79.28 |
| Revenue Growth | 4.06 | ★ 38.80 |
| 52 Week Low | $385.00 | $30.90 |
| 52 Week High | $623.61 | $100.00 |
| Indicator | CHE | AFRM |
|---|---|---|
| Relative Strength Index (RSI) | 31.97 | 40.45 |
| Support Level | $385.00 | $43.73 |
| Resistance Level | $458.07 | $52.86 |
| Average True Range (ATR) | 11.53 | 2.70 |
| MACD | -2.29 | 0.51 |
| Stochastic Oscillator | 10.37 | 49.64 |
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Founded in 2012, Affirm is a market leader in the buy-now, pay-later space with around $36 billion in transaction volume in fiscal 2025. Affirm offers both zero-interest financing, which is merchant subsidized, and interest-bearing loans, which function as personal loans that are approved on a per-transaction basis. Over 70% of Affirm's transaction volume comes from its interest-bearing loans, which also comprise the majority of its revenue. Affirm primarily operates in the United States, which accounted for more than 95% of its revenue in 2025, but the firm has also expanded to Canada and the United Kingdom.